William P. Peters

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

R. Bast, L. Marks, J. Kurtzberg, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

G. Hortobagyi, T. Demirer, J. Caputo, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.

R. Bast, W. Joines, E. Shpall, 1991, Bone marrow transplantation.

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

L. Grochow, R. Bast, H. Seigler, 1987, Cancer research.

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

D. Berry, E. Shpall, G. Broadwater, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.

R. Bast, J. Vredenburgh, W. Peters, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.